Company / Free Cash Flow per Share
Tvardi Therapeutics, Inc. Free Cash Flow per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$17.35
FY2024
5-year range
-$17.35 / -$0.11
FY2020-FY2024
Trend
-1452.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -1452% YoY in FY2024, a notable deviation from the 9-year average annual change of -367%.
Based on SEC 10-K filings.
-17.35 in FY2024.
Declined from $-0.11 to $-17.35 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, free cash flow per share decreased 1452.4% year-over-year.
- Peak free cash flow per share was recorded in FY2015.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$17.35 | -1452.4% |
| FY2023 | -$1.12 | -924.2% |
| FY2022 | -$0.11 | +95.0% |
| FY2021 | -$2.19 | -357.4% |
| FY2020 | -$0.48 | +65.5% |
| FY2019 | -$1.39 | +5.8% |
| FY2018 | -$1.47 | -87.0% |
| FY2017 | -$0.79 | -21.4% |
| FY2016 | -$0.65 | -623.9% |
| FY2015 | $0.12 | +108.8% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026